Cargando…

Chinese vaccine developers gain WHO imprimatur

Detalles Bibliográficos
Autores principales: Jia, Hepeng, Carey, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097606/
https://www.ncbi.nlm.nih.gov/pubmed/21654655
http://dx.doi.org/10.1038/nbt0611-471
_version_ 1783511027137118208
author Jia, Hepeng
Carey, Karen
author_facet Jia, Hepeng
Carey, Karen
author_sort Jia, Hepeng
collection PubMed
description
format Online
Article
Text
id pubmed-7097606
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-70976062020-03-26 Chinese vaccine developers gain WHO imprimatur Jia, Hepeng Carey, Karen Nat Biotechnol Article Nature Publishing Group US 2011-06-07 2011 /pmc/articles/PMC7097606/ /pubmed/21654655 http://dx.doi.org/10.1038/nbt0611-471 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2011 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Jia, Hepeng
Carey, Karen
Chinese vaccine developers gain WHO imprimatur
title Chinese vaccine developers gain WHO imprimatur
title_full Chinese vaccine developers gain WHO imprimatur
title_fullStr Chinese vaccine developers gain WHO imprimatur
title_full_unstemmed Chinese vaccine developers gain WHO imprimatur
title_short Chinese vaccine developers gain WHO imprimatur
title_sort chinese vaccine developers gain who imprimatur
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097606/
https://www.ncbi.nlm.nih.gov/pubmed/21654655
http://dx.doi.org/10.1038/nbt0611-471
work_keys_str_mv AT jiahepeng chinesevaccinedevelopersgainwhoimprimatur
AT careykaren chinesevaccinedevelopersgainwhoimprimatur